Department of Civil and Environmental Engineering, Rice University, Houston, TX 77005, USA.
Sentinel Environmental Group, LLC, Houston, TX 77082, USA.
J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad130.
Fusobacterium varium has been generally overlooked in cattle rumen microbiome studies relative to the presumably more abundant liver abscess-causing Fusobacterium necrophorum. However, F. varium was found to be more abundant in the rumen fluid of cattle and under culture conditions tailored to enrich F. necrophorum. Using near-full length 16S ribosomal ribonucleic acid sequencing, we demonstrate that F. varium grows under restrictive conditions commonly used to enumerate F. necrophorum, suggesting that previous F. necrophorum abundance assessment may have been inaccurate and that F. varium may be an underestimated member of the ruminal bacterial community. Fusobacterium varium were not as susceptible as F. necrophorum to in-feed antibiotics conventionally used in feedlots. Exposure to tylosin, the current gold standard for liver abscess reduction strategies in cattle, consistently hindered growth of the F. necrophorum strains tested by over 67% (P < 0.05) relative to the unexposed control. In contrast, F. varium strains were totally or highly resistant (0%-13% reduction in maximum yield, P < 0.05). Monensin, an ionophore antibiotic, had greater inhibitory activity against F. necrophorum than F. varium. Finally, preliminary genomic analysis of two F. varium isolates from the rumen revealed the presence of virulence genes related to those of pathogenic human F. varium isolates associated with active invasion of mammalian cells. The data presented here encourage further investigation into the ecological role of F. varium within the bovine rumen and potential role in liver abscess development, and proactive interventions.
相比于可能更丰富的导致肝脓肿的坏死梭杆菌,变异梭杆菌在牛瘤胃微生物组研究中通常被忽视。然而,在牛的瘤胃液中和在专门富集坏死梭杆菌的培养条件下,发现变异梭杆菌更为丰富。使用近全长 16S 核糖体核糖核酸测序,我们证明变异梭杆菌在通常用于计数坏死梭杆菌的限制性条件下生长,这表明先前对坏死梭杆菌丰度的评估可能不准确,并且变异梭杆菌可能是瘤胃细菌群落中被低估的成员。与在牛饲料中常规使用的用于饲料的抗生素相比,变异梭杆菌不如坏死梭杆菌容易受到影响。暴露于泰乐菌素,这是目前牛肝脓肿减少策略的黄金标准,与未暴露的对照相比,始终使测试的坏死梭杆菌菌株的生长受到超过 67%的抑制(P < 0.05)。相比之下,变异梭杆菌菌株完全或高度耐药(最大产量减少 0%-13%,P < 0.05)。莫能菌素,一种离子载体抗生素,对坏死梭杆菌的抑制活性大于变异梭杆菌。最后,对来自瘤胃的两个变异梭杆菌分离株的初步基因组分析表明,存在与与哺乳动物细胞主动入侵相关的致病性人类变异梭杆菌分离株相关的毒力基因。这里呈现的数据鼓励进一步研究变异梭杆菌在牛瘤胃中的生态作用以及在肝脓肿发展和主动干预中的潜在作用。